Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 65

Sort by

Sort Order Select

Journal Articles

Development of the First Transgenic Animal Model for IRF4-Induced Lymphoid Malignancy

Stella Amanda, MSc, BSc, Regina Wong, Tze King Tan, PhD, Muhammad Zulfaqar Ali, MSc, BSc, Yan Li, PhD, Zhi Yuan Gong, PhD, Shinsuke Iida, MD PhD, Takaomi Sanda, MD PhD

Blood (2019) 134 (Supplement_1): 1242.

https://doi.org/10.1182/blood-2019-129714

Published: 2019

Journal Articles

Hepatosplenic T Cell Lymphoma Case Report Presented with Hemphagocytosis Lymphohistiocytosis

Mohamed Abu Haleeqa, MBBS, Fatemah Alshehi, MBBS, Gannat Alghamrawi, MBBS, Lois Richard

Blood (2019) 134 (Supplement_1): 5363.

https://doi.org/10.1182/blood-2019-126445

Published: 2019

Journal Articles

"Real-World" Peripheral T-Cell Lymphomas Experience in Portugal: Is There Reason for Optimism?

Ivan Dlouhy, Rita Gavancha, MD, Inês Coelho, MD, Catalina Gomez, MD, Inês Barbosa, MD, Susana Carvalho, MD, Maria Ceu Trindade, MD, Ana Filipa Moita, Gonçalo Esteves, MD, Paula Gameiro, Jose Cabecadas, Maria Silva, MD

Blood (2019) 134 (Supplement_1): 5287.

https://doi.org/10.1182/blood-2019-124485

Published: 2019

Journal Articles

A Comprehensive Analysis of Rhoa Mutation Positive and Negative Angioimmunoblastic T-Cell Lymphomas By Targeted Deep Sequencing, Expression Profiling, and Single Cell Digital Image Analysis

Alexandra Butzmann, MD, Kaushik Sridhar, MS, Diwash Jangam, PhD, Jyoti Kumar, MDMS, Malaya K Sahoo, PhD, Nahid Shahmarvand, MD, Roger A Warnke, MD, Elumalai Rangasamy, PhD, Benjamin A Pinsky, MD PhD, Robert S. Ohgami, MD PhD

Blood (2019) 134 (Supplement_1): 5228.

https://doi.org/10.1182/blood-2019-129560

Published: 2019

Journal Articles

Interleukin-15 (IL-5) in Combination with Avelumab in Relapsed/Refractory Mature T-Cell Malignancies

Milos D. Miljkovic, MDMSc, Kevin C Conlon, MD, Sigrid Dubois, PhD, Jennifer Hsu, RN, Jeffrey Schlom, PhD, James Gulley, MD PhD, Thomas A. Waldmann, MD

Blood (2019) 134 (Supplement_1): 1558.

https://doi.org/10.1182/blood-2019-128945

Published: 2019

Journal Articles

Ectonucleosidase CD39 Is Highly Expressed on ATLL Cells and Suppresses the Immune Response through the Adenosine Pathway

Yasuhiro Nagate, MD, Sachiko Ezoe, MD PhD, Jiro Fujita, MD PhD, Takafumi Yokota, MD PhD, Michiko Ichii, MD PhD, Akira Tanimura, Yukiko Doi, Tomoaki Ueda, Jun Toda, MD, Hirohiko Shibayama, MD PhD, Kenji Oritani, MD PhD, Yuzuru Kanakura, MD PhD

Blood (2018) 132 (Supplement 1): 3720.

https://doi.org/10.1182/blood-2018-99-118555

Published: 2018

Journal Articles

Phase I Study of Yttrium-90 Labeled ANTI-CD25 (aTac) Monoclonal Antibody PLUS BEAM for Autologous Hematopoietic CELL Transplantation (AHCT) in Patients with Mature T-CELL NON-Hodgkin Lymphoma, the "a-TAC-BEAM Regimen"

Jasmine Zain, MD, Jennifer Simpson, Joycelynne Palmer, Jeffrey Wong, MD, Savita Dandapani, MD PhD, David Colcher, PhD, Nicole Karras, MD, Alex F. Herrera, MD, Amandeep Salhotra, MD, Auayporn P. Nademanee, MDBS, Ryotaro Nakamura, MD, Eileen P. Smith, MD, Ni-Chun Tsai, David Yamauchi, MD, Kofi Poku, PharmD, Van Biglang-awa, PharmD, John E. Shively

Blood (2018) 132 (Supplement 1): 611.

https://doi.org/10.1182/blood-2018-99-116907

Published: 2018

Journal Articles

Distribution of Lymphomas in Mexico: A Descriptive Study

Alejandro Garcia-Horton, MD, Adrian Carballo-Zarate, Lizbeth Palma-Berre, Patricia Ramos-Salazar, Rogelio Sanchez-Verin-Lucio, Jorge Valenzuela-Tamariz, Lourdes Molinar-Horcasitas, Alejanda Zarate-Osorno, Alejandro Lazo-Langner, MD MSc

Blood (2017) 130 (Supplement 1): 2127.

https://doi.org/10.1182/blood.V130.Suppl_1.2127.2127

Published: 2017

Journal Articles

Efficacy of Autologous Stem Cell Transplantation in First Complete Remission in Patients with Peripheral T-Cell Lymphoma: A Multicenter Geltamo/FIL Study

Blood (2017) 130 (Supplement 1): 2008.

https://doi.org/10.1182/blood.V130.Suppl_1.2008.2008

Published: 2017

Journal Articles

Preclinical Development of a T-Cell ALL CAR Demonstrates That Differences in CAR Membrane Distribution May Impact Efficacy

Haneen Shalabi, DO, Haiying Qin, MS, Kelsey Wanhainen, BS, Jillian Smith, BS, Rimas Orentas, PhD, Nirali N Shah, MD, Shannon L Maude, MD PhD, Sarah K Tasian, MD, David T Teachey, MD, Javed Khan, MD, Terry J Fry, MD

Blood (2016) 128 (22): 4019.

https://doi.org/10.1182/blood.V128.22.4019.4019

Published: 2016

Journal Articles

Characteristics, Outcomes and Treatment of Patients with T-Cell Prolymphocytic Leukemia (T-PLL) - Single-Center Experience

Etsuko Aoki, MDPhD, Preetesh Jain, MBBS, MDDM, PhD, Alessandra Ferrajoli, MD, Zeev Estrov, MD, Michael Keating, MBBS, Susan M. O'Brien, MD, William G. Wierda, MD PhD, Nitin Jain, MD, Philip A Thompson, MBBS, Elias Jabbour, MD, Sherry Pierce, BSN, BA, Chitra Hosing, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Tapan M. Kadia, MD

Blood (2016) 128 (22): 2997.

https://doi.org/10.1182/blood.V128.22.2997.2997

Published: 2016

Journal Articles

A Dose Escalation Study of RP6530, a Novel Dual PI3K δ/γ Inhibitor, in Patients with Relapsed/Refractory T-Cell Lymphoma

Yasuhiro Oki, MD, Auris Huen, MD, Prajak J Barde, MD, Kumar Penmetsa, PhD, Alda Ashu, Little Pullokaran, Carol Wilson, Srikant Viswanadha, PhD, Madeleine Duvic, MD

Blood (2016) 128 (22): 3004.

https://doi.org/10.1182/blood.V128.22.3004.3004

Published: 2016

Journal Articles

Identification of Targeted Therapies for Rare Adult Mature T-Cell Leukemia Using Functional Ex Vivo Screening of Primary Patient Samples

Uma Borate, MD, Brianna A. Norris, Pierrette Lo, MS, Cristina E. Tognon, Brian Junio, Jeffrey W. Tyner, Brian J. Druker, MD

Blood (2016) 128 (22): 4720.

https://doi.org/10.1182/blood.V128.22.4720.4720

Published: 2016

Journal Articles

CHOP in Combination with Pralatrexate, a Novel Folate Analogue Metabolic Inhibitor in Patients with Previously Untreated Peripheral T-Cell Lymphoma (PTCL): Interim Results of the Phase 1 Trial

Andrei R. Shustov, MD, Yasuhiro Oki, MD, Stefan Klaus Barta, MD MRCP, MS, Patrick B. Johnston, MD PhD, Pankaj Sharma, Tao Song, Sanjay Mourya

Blood (2016) 128 (22): 5355.

https://doi.org/10.1182/blood.V128.22.5355.5355

Published: 2016

Journal Articles

An International Assessment of Event-Free Survival at 24 Months (EFS24) and Subsequent Survival in Peripheral T-Cell Lymphoma

Matthew J Maurer, MS, Fredrik Ellin, MDPhD, Line Srour, MD, Mats Jerkeman, Nabila Nora Bennani, MD, Joseph M. Connors, Karin Ekstrom Smedby, MD PhD, Stephen Ansell, MD PhD, Brian K Link, MD, James R Cerhan, MD PhD, Thomas Relander, MD PhD, Kerry J Savage, MD, Andrew L Feldman, MD

Blood (2016) 128 (22): 920.

https://doi.org/10.1182/blood.V128.22.920.920

Published: 2016

Journal Articles

Romidepsin in Relapsed/Refractory HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia: A Case Series

Nikhil Mukhi, MD, Vaibhav Verma, MBBS, Anam Ahmed, MD, Hana Lim, MD, Jason Gonsky, MD PhD, Gurinder Sidhu, MD

Blood (2015) 126 (23): 5113.

https://doi.org/10.1182/blood.V126.23.5113.5113

Published: 2015

Journal Articles

Comprehensive Genomic Profiling (CGP) of Angioimmunoblastic T-Cell Lymphoma (AITL) to Prospectively Inform Diagnosis and Clinical Management

Samantha Morley, PhD, Jie He, PhD, Andrew M. Intlekofer, MD PhD, Mark Bailey, MS, Michelle Nahas, PhD, Doron Lipson, PhD, Roman Yelensky, PhD, Jeffrey Ross, MD, Siraj Ali, MD PhD, Rachel Erlich, PhD, Phil Stephens, PhD, Vincent A. Miller, MD, Jo-Anne Vergilio, MD, Tariq I Mughal, MD

Blood (2015) 126 (23): 3898.

https://doi.org/10.1182/blood.V126.23.3898.3898

Published: 2015

Journal Articles

Frontline Treatment of CD30+ Peripheral T-Cell Lymphomas with Brentuximab Vedotin in Combination with CHP: 3-Year Durability and Survival Follow-up

Steven M Horwitz, MD, Andrei R. Shustov, MD, Andres Forero-Torres, Nancy L Bartlett, MD, Ranjana Advani, Barbara Pro, Robert Chen, Andrew J Davies, MRCP, Tim Illidge, Dirk Huebner, Dana A. Kennedy, Michelle A. Fanale

Blood (2015) 126 (23): 1537.

https://doi.org/10.1182/blood.V126.23.1537.1537

Published: 2015

Journal Articles

Integrated Genome Sequencing Reveals Frequent Loss of Function Alterations of ARID1A and Other Epigenetic Modifiers in Sezary Syndrome

Mark Kiel, MDPhD, Anagh A Sahasrabuddhe, PhD, Thiru Velusamy, PhD, Fuzon Chung, PhD, Nathanael G. Bailey, MD, Bryan L Betz, PhD, David W Bahler, MD PhD, Roberto N. Miranda, MD, L. Jeffrey Medeiros, MD, Megan S Lim, MD PhD, Kojo S.J. Elenitoba-Johnson, MD

Blood (2014) 124 (21): 706.

https://doi.org/10.1182/blood.V124.21.706.706

Published: 2014

Journal Articles

Induction Treatment with Alemtuzumab Combined with Polychemotherapy Containing Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) Followed By Alemtuzumab Maintenance in Patients with T-Cell Prolymphocytic Leukaemia (T-PLL): First Analysis of a Prospective Multicenter Phase-II-Trial (T-PLL2) Conducted By the German CLL Study Group (GCLLSG)

Natali Pflug, MD, Georg Hopfinger, MD, Paula Cramer, MD, Alexandra Schrader, PhD, Nicole Weit, PhD, Rita Meister, Miriam Thiel, Tanja Annolleck, Anne Westermann, Till M Seiler, MD, Thorsten Zenz, MD, Jan Duerig, MD, Jasmin Bahlo, Karl-Anton Kreuzer, MD, Stephan Stilgenbauer, MD, Anna-Maria Fink, MD, Barbara Eichhorst, MD, Michael Hallek, MD, Marco Herling, MD

Blood (2014) 124 (21): 1999.

https://doi.org/10.1182/blood.V124.21.1999.1999

Published: 2014

NARROW

Development of the First Transgenic Animal Model for IRF4-Induced Lymphoid Malignancy

Hepatosplenic T Cell Lymphoma Case Report Presented with Hemphagocytosis Lymphohistiocytosis

"Real-World" Peripheral T-Cell Lymphomas Experience in Portugal: Is There Reason for Optimism?

A Comprehensive Analysis of Rhoa Mutation Positive and Negative Angioimmunoblastic T-Cell Lymphomas By Targeted Deep Sequencing, Expression Profiling, and Single Cell Digital Image Analysis

Interleukin-15 (IL-5) in Combination with Avelumab in Relapsed/Refractory Mature T-Cell Malignancies

Ectonucleosidase CD39 Is Highly Expressed on ATLL Cells and Suppresses the Immune Response through the Adenosine Pathway

Phase I Study of Yttrium-90 Labeled ANTI-CD25 (aTac) Monoclonal Antibody PLUS BEAM for Autologous Hematopoietic CELL Transplantation (AHCT) in Patients with Mature T-CELL NON-Hodgkin Lymphoma, the "a-TAC-BEAM Regimen"

Distribution of Lymphomas in Mexico: A Descriptive Study

Efficacy of Autologous Stem Cell Transplantation in First Complete Remission in Patients with Peripheral T-Cell Lymphoma: A Multicenter Geltamo/FIL Study

Preclinical Development of a T-Cell ALL CAR Demonstrates That Differences in CAR Membrane Distribution May Impact Efficacy

Characteristics, Outcomes and Treatment of Patients with T-Cell Prolymphocytic Leukemia (T-PLL) - Single-Center Experience

A Dose Escalation Study of RP6530, a Novel Dual PI3K δ/γ Inhibitor, in Patients with Relapsed/Refractory T-Cell Lymphoma

Identification of Targeted Therapies for Rare Adult Mature T-Cell Leukemia Using Functional Ex Vivo Screening of Primary Patient Samples

CHOP in Combination with Pralatrexate, a Novel Folate Analogue Metabolic Inhibitor in Patients with Previously Untreated Peripheral T-Cell Lymphoma (PTCL): Interim Results of the Phase 1 Trial

An International Assessment of Event-Free Survival at 24 Months (EFS24) and Subsequent Survival in Peripheral T-Cell Lymphoma

Romidepsin in Relapsed/Refractory HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia: A Case Series

Comprehensive Genomic Profiling (CGP) of Angioimmunoblastic T-Cell Lymphoma (AITL) to Prospectively Inform Diagnosis and Clinical Management

Frontline Treatment of CD30+ Peripheral T-Cell Lymphomas with Brentuximab Vedotin in Combination with CHP: 3-Year Durability and Survival Follow-up

Integrated Genome Sequencing Reveals Frequent Loss of Function Alterations of ARID1A and Other Epigenetic Modifiers in Sezary Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only